(Q62105565)
Statements
A Phase 3B, Multicenter, Open-Label Study Investigating the Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Who Have Not Achieved Glycemic Targets With Insulin Therapy (English)
0 references
April 2003
0 references
June 2005
0 references
400
0 references